Recently, Su and colleagues demonstrated that breast-tumor-cell-derived GMCSF drives the accumulation of ARG1-expressing myeloid cells, well-known markers of inhibition of host antitumor immunity, and then dictates the acquisition of the immunosuppressive TME [41]. Here, ARG1 is linked to breast neoplasm.